Compugen Ltd

CGEN

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001119774

SEC filings (opens in a new tab)

In the last 90 days, Compugen Ltd insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; ARK Invest is the only superinvestor holding it.

Q3 2023 vs. Q2 2023

How the institutions holding Compugen Ltd changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of CGEN: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	69	66	−3
Shares	11.5M	12.6M	+1.13M (+9.8%)
Value	$13.1M	$11.7M	−$1.39M (−10.6%)

New holders (10)

Institutions that held Compugen Ltd at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to CGEN in Q3 2023
Institution	Shares	Value	% of portfolio
Verition Fund Management LLC	740,911	$689.0K	0.01%
Millennium Management LLC	363,728	$338.3K	0.00%
Kingsview Wealth Management, LLC	83,991	$78.1K	0.00%
Tocqueville Asset Management L.P.	76,500	$71.1K	0.00%
Vident Advisory, LLC	43,492	$40.4K	0.00%
Virtu Financial LLC	23,962	$22.0K	0.00%
XTX Topco Ltd	18,426	$17.1K	0.00%
Cetera Advisor Networks LLC	15,495	$14.1K	0.00%
Qube Research & Technologies Ltd	106	$99	0.00%
JPMorgan Chase & Co	6	$6	0.00%

Sold out (13)

Institutions that held Compugen Ltd at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of CGEN in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Vident Investment Advisory, LLC	44,066	$50.2K
Csenge Advisory Group	41,345	$47.1K
Citigroup Inc	27,316	$31.1K
Two Sigma Securities, LLC	25,213	$28.7K
Northern Trust Corp	19,771	$22.5K
Cubist Systematic Strategies, LLC	19,018	$21.7K
Susquehanna International Group, LLP	18,781	$21.4K
Quent Capital, LLC	10,080	$11.5K
Citadel Advisors LLC	2,563	$2.92K
Tower Research Capital LLC (TRC)	1,000	$1.14K
FMR LLC	176	$201
Simplex Trading, LLC	113	$0
CWM, LLC	65	$0